MDGL FY 2016 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MDGLMadrigal Pharmaceuticals, Inc.

$10B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$156

Operating Income

-$25M

Net Income

-$26M

EPS (Diluted)

$-5.07

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$41M

Total Liabilities

$5M

Stockholders' Equity

$36M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$156	$0	—
Operating Income	-$25M	-$3M	-687.8%
Net Income	-$26M	-$7M	-285.5%